Curriculum Vitae · Postdoctoral Applicant Boston, MA · Open to relocate
Truman Burbank Ph.D.
single-cell / spatial multi-omics · ML/DL · connectome-scale neuroscience
tel(555) 019-2847 mailtruman.burbank@example.com loc220 Harbor Street, Boston, MA 02135 webGoogle Scholar · CV site
18
Total papers
6
First / co-first
IF 27.7
Nat. Immunol. (under review)
0.780
Classifier AUC

# Profile

Moving from wet-lab immunology into computational neuroscience. I build methods that infer cellular identity, state, and interaction from large, incomplete single-cell and spatial data. Research objective: connect molecular cell identity to circuit structure and function by integrating connectomics with transcriptomics, growing into connectome-constrained circuit models.

# Experience

Postdoctoral Researcher2025–2026
Nakdong University Wonju College of Medicine · Physiology / Cellular Systems Research Center
Developed deep-learning multimodal-integration models fusing imaging, transcriptomic, and clinical data into single predictive models.
Associate Director2023–2025
Meridian Immune Therapeutics Inc. · Basic Research, Seoul
Built in-house single-cell & spatial transcriptomics code from scratch; led cross-functional NHP (cynomolgus, marmoset) EAE/MS multi-omic studies; oversaw regulatory documentation for an anti-CD25 humanized-antibody program.
Manager2021–2023
Meridian Immune Therapeutics Inc. · Basic Research, Seoul
Researcher2019–2021
Xenotransplantation Research Center, HNU · Seoul
Rhesus macaque tissue processing, longitudinal immune monitoring, CNS (brain/spinal cord) tissue handling.
Research Student2020–2023
MOSAIC, Genomic Medicine Institute, HNU · Multi-Organ Single-cell Atlas of Immune Cells
Contributed the founding proposal; executed within the funded program (500+ donors × 6 organs): milestone tracking, multi-site QC, multi-PI coordination.

# Selected Publications

01Reyes M*, Burbank T*, Alvarez T*, et al. Conserved PDE9X short-isoform bias defines pathogenic Th1.17 state across human inflammatory diseases. Nature Immunology IF 27.7 under review 2026. UMI-aware BAM-level isoform analysis; scRNA + scTCR + snATAC integration; ML classifier AUC 0.812; 702 samples, 251,055 CD4⁺ T cells.
02Burbank T*, Tanaka Y*, Truong P*, et al. Immune cell-enriched scRNA-seq unveils infiltrated CD8⁺ T resident memory cells and meningeal lymphatic endothelium in Parkinson's disease. Journal of Neuroimmunology IF 2.9 · 2025. 9,240 cells, 8 immune populations.
03Burbank T*, Delgado J*, Moreau S, et al. Deciphering Dysfunctional Regulatory T Cells in Vitiligo. Allergy IF 12.6 · 2025.
04Alvarez J*, Burbank T*, et al. Long-term control of diabetes by a baricitinib-based regimen after allo-islet transplantation in rhesus monkeys. Xenotransplantation IF 3.9 · 2024.
05Novak L*, Burbank T*, et al. Intra-tumoral heterogeneity and immune escape of melanoma arising from chronic UV photodamage by spatial gene expression. JEADV IF 9.2 · 2022.
06Burbank T*, et al. mTOR inhibitor-based immunosuppression in allogeneic islet transplantation. Islets IF 2.2 · 2019.
Co-author (selected): eBioMedicine (IF 11.1, 2024) · JEADV (IF 9.2, 2024) · Current Diabetes Reports (IF 4.2, 2021).

# Education

Ph.D., Biomedical Sci.2014–2023
Hangang National University · Seoul
Dendritic Cell Heterogeneity Across Chronic Inflammatory Contexts. Advisor: Min-Ho Suh, M.D., Ph.D.
M.S., Biomedical Sci.2012–2014
Hangang National University · Seoul
B.S., Genetic Eng.2008–2012
Suwon Institute of Life Sciences · Suwon

# Technical Skills

single-cell / spatialscRNA/scTCR/snATAC; Seurat, Scanpy, Squidpy, Monocle3, CellChat/NicheNet; scVI/scANVI, consensus NMF; custom UMI-aware BAM isoform code (Python); Milo, GLIPH, InferCNV; GeoMx DSP; Olink.
ml / dl / aiPython (scikit-learn, XGBoost/LightGBM/CatBoost, PyTorch); AUC-validated classifiers; VAE/GAN/GNN; multimodal DL (imaging + transcriptomic + clinical); AlphaFold2/3, ProteinMPNN, DiffDock; Linux, R, Git.
experimental10x 5′/3′ scRNA + scTCR libraries; flow cytometry (24 markers); brain/CNS immune profiling; IHC/IF; two-photon; NHP CNS tissue (rhesus, cynomolgus, marmoset); EAE/MS & islet models.

# Awards & Patents

  • Anti-CD25 Humanized Antibody (Patent)2024
  • Immunosuppression w/ PI3K Inhibitor (Patent)2019
  • Grand Prize, AI Builders Hackathon2024
  • Grand Prize, Metro Innovation Workathon2023
  • Best Poster, ATC Chicago2017
  • NRF Ph.D. · BK21 Plus · HNU Dean's2014–20

# References

Min-Ho Suh, M.D., Ph.D.
HNU; CEO/CSO, Meridian Immune. Ph.D. advisor.
mhsuh@hangang.ac.kr
Ji-Won Baek, M.D., Ph.D.
HNU, Microbiology & Immunology / IBRI.
jwbaek@hangang.ac.kr
Dae-Ho Yoon, Ph.D.
Nakdong Wonju, Physiology. Recent supervisor.
dhyoon@nakdong.ac.kr